Home/Filings/4/0001628280-20-003793
4//SEC Filing

Fair Richard A. 4

Accession 0001628280-20-003793

CIK 0001358403other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 12:48 PM ET

Size

6.0 KB

Accession

0001628280-20-003793

Insider Transaction Report

Form 4
Period: 2020-03-17
Fair Richard A.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2020-03-17$4.00/sh+5,000$19,9995,000 total(indirect: By Trust)
Holdings
  • Common Stock

    6,813
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F2]Includes 157 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001695851

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 12:48 PM ET
Size
6.0 KB